Lineus Medical Elevates Leadership to Accelerate Growth After Breakthrough Clinical Results
ncarol.com/10335483

FAYETTEVILLE, Ark. - ncarol.com -- Lineus Medical, maker of SafeBreak Vascular, has seen breakthrough clinical results at multiple hospital systems across the U.S. that validate the clinical and health-economic value proposition for SafeBreak, the first breakaway device for IV lines.

The cumulative data, cultivated through evidence-based medicine and demonstrated across tens of thousands of patients, is convincing and has clearly demonstrated SafeBreak's value, use, and adoption as a true standard of care. Based on the clinical success seen to date, additional capital has been raised to accelerate commercial efforts in the U.S., Europe, Latin America, and Asia.

To support this growth, the company has promoted Larry Hayes to President and Chief Commercial Officer. In his expanded role, Larry will oversee the company's marketing, sales, manufacturing, and human resources functions, consolidating operational leadership under a single point of accountability as Lineus scales its commercial operations.

More on ncarol.com

• RAS AP Consulting Expands Managed AP Governance™ Ecosystem, Launches Trademark Process, and Secures IFOL Speaker Invitation
• UK Financial Ltd Makes History: Chainlink CRE Circulating Supply Verification Goes Live Across Its Complete Ecosystem Of Nine Exchange-Traded Tokens
• International Rights Groups Raise Alarm Over Freedom of Religion and Expression in South Korea
• The City's Most Elegant Open-Air Dinner Party Returns September 12, 2026
• FDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP)

"I'm honored to take on this role at such a pivotal moment for Lineus Medical. We have built tremendous momentum over the past year. Stepping into this role, alongside my commercial responsibilities, gives me a broader hand in how we scale our growth long-term. We're not changing direction, we're accelerating it," said Hayes.

"This new leadership structure, alongside recent investments, reflects the confidence we have in Lineus Medical's trajectory. Larry has been instrumental in establishing Lineus' Clinical Evidence Program through the Breakaway Impact Registry, a key to the company's commercial success. This expanded role positions Larry to help lead our next stage of growth," said Jonathon Fite, Chairman of the Board.

CEO and co-founder, Vance Clement, will continue to lead the company with a renewed passion on next generation vascular access solutions. "I am excited to focus on the long-term future of Lineus Medical and the scientific advancement of our intellectual property and product portfolio," said Vance Clement.

More on ncarol.com

• Autonomous Robotics Platform Expansion as Public Market Debut is Very Close: MBody AI Corp. (N A S D A Q: MBAI)
• New Book gives Consumer Goods Leaders a Governance Playbook for Generative and Agentic AI
• Loud! OOH calls for prize draw advertising standards as £1.3bn category moves outdoors
• Black Ribbon Productions Launches With Fearless 2026 Horror Slate
• Actor Dominic Pace Returns to Television and Film

Additionally, Lineus announces the appointment of Pravin Raj to its Board of Directors. Mr. Raj's services and technology background to help organizations scale will complement the company's near-term commercialization and long-term portfolio development goals.

SafeBreak Vascular is a breakaway device for IV lines that separates when a damaging force is applied to IV lines, removing the damaging forces and protecting the patient's IV line. When separation occurs, valves on both ends of the device close to prevent medication spills from the pump, and blood loss from the patient. SafeBreak has been shown to reduce mechanical IV complications in a range of 44%-91%.¹ The device is FDA-cleared for use across all vascular lines, CE Mark certified for use across the European Union, and is distributed across markets spanning more than three continents.

About Lineus Medical
Lineus Medical is the developer of SafeBreak Vascular, a breakaway technology proven to reduce IV complications.¹ Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical for more on LinkedIn, Facebook, and Instagram.
Reference:

1. Data on File.